Biocon Ltd, an innovation-led global biopharmaceutical company, said its long-standing partner, Duopharma Biotech Berhad, through its wholly owned subsidiary Duopharma (M) Sendirian Berhad, has secured multiple insulin supply contracts from Malaysia’s Ministry of Health (MoH) worth more than MYR 225 million. Under the contracts, Biocon’s Malaysian subsidiary, Biocon Sdn. Bhd., will supply short-acting recombinant human […]